What is the recommended dosing for a Z-pack (azithromycin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Z-Pack Dosing for Azithromycin

The standard Z-pack regimen is 500 mg on day 1, followed by 250 mg once daily on days 2 through 5, for a total 5-day course. 1, 2, 3

Standard Adult Dosing Regimens by Indication

Respiratory Tract Infections

  • For community-acquired pneumonia, acute bacterial sinusitis, and bronchitis: 500 mg on day 1, then 250 mg once daily on days 2-5 (total 5 days) 1, 2, 3
  • Alternative 3-day regimen: 500 mg once daily for 3 consecutive days provides the same total 1.5 gram dose and is equally effective for respiratory infections 2, 3, 4
  • For acute bacterial exacerbations of COPD: Either 500 mg daily for 3 days OR the standard 5-day regimen (500 mg day 1, then 250 mg days 2-5) 3

Sexually Transmitted Infections

  • For non-gonococcal urethritis and cervicitis (Chlamydia): Single 1 gram dose orally 1, 2, 3
  • For chancroid (genital ulcer disease): Single 1 gram dose 3
  • Critical advantage: Single-dose regimens allow for directly observed therapy and dramatically improve compliance, particularly important in populations unlikely to return for follow-up 1

Pharyngitis/Tonsillitis

  • Azithromycin is NOT first-line for streptococcal pharyngitis due to increasing macrolide resistance in Group A Streptococcus 2
  • If used as second-line therapy (penicillin allergy): 500 mg day 1, then 250 mg days 2-5 3
  • Important caveat: Azithromycin results in more recurrence of streptococcal infection than penicillin V, necessitating careful patient selection 5

Long-Term Prophylactic Regimens

  • For bronchiectasis with ≥3 exacerbations per year: Azithromycin 500 mg three times weekly has the strongest evidence for reducing exacerbations 6, 1
  • Alternative long-term dosing: 250 mg daily also has strong supportive evidence 6, 1
  • Minimum duration: Therapy should continue for at least 6 months to demonstrate benefit in exacerbation reduction 6, 1
  • For bronchiolitis obliterans syndrome in lung transplant recipients: 250 mg daily for 5 days, then 250 mg three times weekly for at least 3 months 6, 1

Pediatric Dosing

Respiratory Tract Infections

  • Standard 5-day regimen: 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg once daily (maximum 250 mg/day) on days 2-5 2, 3, 5
  • Alternative 3-day regimen: 10 mg/kg once daily for 3 consecutive days 3, 5
  • For acute otitis media only: Single 30 mg/kg dose (maximum 1500 mg) is an option 3

Pharyngitis/Tonsillitis in Children

  • Higher dose required: 12 mg/kg once daily for 5 days (maximum 500 mg/day) due to higher recurrence rates with standard dosing 7, 3, 5

Pertussis

  • Infants <6 months: 10 mg/kg per day for 5 days 1, 2
  • Children ≥6 months: 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg (max 250 mg) on days 2-5 1, 2

Critical Administration Considerations

Food and Drug Interactions

  • Azithromycin can be taken with or without food 2, 3
  • Separate from antacids by at least 2 hours: Aluminum- or magnesium-containing antacids reduce absorption by up to 50% 1, 2, 8

Safety Monitoring for Long-Term Therapy

  • Obtain baseline ECG to assess QTc interval before initiating long-term therapy 1, 2
  • Contraindication: QTc >450 ms (men) or >470 ms (women) 1, 2
  • Measure baseline liver function tests for long-term therapy 1
  • Avoid in patients taking other QT-prolonging medications without careful risk assessment 1

Common Pitfalls and Clinical Pearls

Compliance Optimization

  • Dispense medication on-site when possible and directly observe the first dose to maximize adherence 1, 2
  • For STI treatment: Patients should abstain from sexual intercourse for 7 days after completing therapy 1

Resistance Concerns

  • Never use azithromycin as monotherapy for gonorrhea due to widespread resistance; must combine with ceftriaxone if gonococcal infection suspected 1, 2
  • Long-term macrolide use increases antimicrobial resistance, though clinical impact remains uncertain 6

Adverse Effects

  • Common side effects: Diarrhea, abdominal pain, nausea, vomiting (less frequent than erythromycin) 6, 1, 5, 8
  • Gastrointestinal symptoms are generally mild to moderate and better tolerated than amoxicillin/clavulanic acid in children 5

Special Populations

  • Pregnancy: Classified as FDA Pregnancy Category B and considered safe 1, 2
  • Infants <1 month: Azithromycin is preferred over erythromycin due to lower risk of infantile hypertrophic pyloric stenosis 1, 2
  • Severe renal impairment (GFR <10 mL/min): Use with caution as AUC increases 35% compared to normal renal function 3
  • Hepatic impairment: No dose adjustment recommendations available due to lack of pharmacokinetic data 3

References

Guideline

Azithromycin Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Azithromycin Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Azitromicina en Amigdalitis Estreptocócica

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.